George Hill's Stock Ratings

Deutsche Bank Analyst

George Hill is an analyst at Deutsche Bank. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/17/2024

Overall Average Return

2.78%

Smart Score

59.6%

Overall Average Return Percentile

41st

Number of Ratings

120
Buy NowGet Alert
05/09/2024MCKBuy Now
McKesson
$552.39-1.34%$547 → $545MaintainsBuyGet Alert
05/09/2024DHBuy Now
Definitive Healthcare
$5.6523.89%$10 → $7MaintainsHoldGet Alert
05/07/2024HIMSBuy Now
Hims & Hers Health
$17.66-9.4%$14 → $16MaintainsHoldGet Alert
04/30/2024CNCBuy Now
Centene
$78.404.59%$81 → $82MaintainsHoldGet Alert
04/19/2024UNHBuy Now
UnitedHealth Group
$523.557.34%$545 → $562MaintainsBuyGet Alert
04/03/2024WBABuy Now
Walgreens Boots Alliance
$16.7231.58%$23 → $22MaintainsHoldGet Alert
03/19/2024MDRXBuy Now
Veradigm
——$15 → $10DowngradeBuy → HoldGet Alert
02/01/2024CIBuy Now
Cigna Group
$336.389.99%$355 → $370UpgradeHold → BuyGet Alert
01/25/2024HUMBuy Now
Humana
$355.631.23%$595 → $360DowngradeBuy → HoldGet Alert
12/12/2023CIBuy Now
Cigna Group
$336.385.54%$351 → $355MaintainsHoldGet Alert
11/21/2023AGLBuy Now
Agilon Health
$5.55116.22%$27 → $12DowngradeBuy → HoldGet Alert
09/22/2023WBABuy Now
Walgreens Boots Alliance
$16.7261.48%$34 → $27MaintainsHoldGet Alert
09/07/2023HQYBuy Now
HealthEquity
$79.31-9.22%$71 → $72MaintainsBuyGet Alert
09/05/2023FDSBuy Now
FactSet Research Systems
$449.934.68%$461 → $471MaintainsBuyGet Alert
08/10/2023GDRXBuy Now
GoodRx Holdings
$7.1611.73%$6 → $8MaintainsHoldGet Alert
08/09/2023EHTHBuy Now
eHealth
$5.3686.57%$5 → $10MaintainsHoldGet Alert
08/07/2023HUMBuy Now
Humana
$355.6376.59%$468 → $628MaintainsBuyGet Alert
07/17/2023UNHBuy Now
UnitedHealth Group
$523.556.01%$564 → $555MaintainsBuyGet Alert
06/28/2023WBABuy Now
Walgreens Boots Alliance
$16.72103.35%$46 → $34DowngradeBuy → HoldGet Alert
06/16/2023UNHBuy Now
UnitedHealth Group
$523.557.73%$627 → $564MaintainsBuyGet Alert
06/07/2023HQYBuy Now
HealthEquity
$79.31-10.48%$69 → $71MaintainsBuyGet Alert
05/15/2023AGLBuy Now
Agilon Health
$5.55386.49%$28 → $27MaintainsBuyGet Alert
05/08/2023CAHBuy Now
Cardinal Health
$96.01-6.26%$88 → $90MaintainsHoldGet Alert
05/08/2023CIBuy Now
Cigna Group
$336.38-7.84%$384 → $310MaintainsHoldGet Alert
05/08/2023MOHBuy Now
Molina Healthcare
$342.32-2.14%$365 → $335MaintainsHoldGet Alert
05/01/2023MOHBuy Now
Molina Healthcare
$342.326.63%$356 → $365MaintainsHoldGet Alert
04/28/2023TDOCBuy Now
Teladoc Health
$11.83145.14%$27 → $29MaintainsHoldGet Alert
04/27/2023RADBuy Now
Rite Aid
——$3 → $1MaintainsSellGet Alert
04/26/2023CAHBuy Now
Cardinal Health
$96.01-8.34%$77 → $88MaintainsHoldGet Alert
04/17/2023UNHBuy Now
UnitedHealth Group
$523.5519.76%$617 → $627MaintainsBuyGet Alert

Recent Analyst Stock Rating News

Amal Clooney Gave Advice To ICC On Arrest Warrants For Benjamin Netanyahu, Top Israeli Officials: 'The Law ...Applies In Every Country In The World'
10 Analysts Assess Centene: What You Need To Know
Gold Co. Releases Maiden Resource Estimate for Historic SD Project
Source: Streetwise Reports 04/30/2024
Trump VP Pool, Including A Mystery Candidate, Put On Notice By Anti-Abortion Group: 'GOP Ticket Poses A Significant Threat'
NBA Team Owner Runs For President In 2024 Election — No, It's Not Mark Cuban
An NBA team owner has entered the bid for the White House in the 2024 presidential election.
Chris Sununu Voices Support For Trump Despite Belief Ex-President Played A Role In Jan.6 Capitol Riots: 'As Does 51 Percent Of America'
Co. Continues High-Grade Gold Streak Near Historic South Dakota Mine
Source: Streetwise Reports 04/08/2024
Where Cigna Group Stands With Analysts
Trump 'Either Is Stupid, Or He Thinks The Rest Of Us Are,' Says Nancy Pelosi On Ex-President's Abortion Stance
Pelosi mocked this position, suggesting Trump's true motive is political survival rather than any genuine belief.
Trump Has 'Taken Most Unfavorable Political Position' On Abortion, Says Ex-Bush Strategist
Former Bush strategist Matthew Dowd criticizes Trump's abortion stance, suggesting a 15-16 week policy would have been better. Trump's statement faces backlash and could hurt his chances in upcoming elections.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free